Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL0WW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,704
Award facts
- Contract value 100% obligated
- $14,703.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,703.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen medication on January 6, 2026, with completion expected by January 7, 2026. This contract was awarded on a full and open competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which functions as a comprehensive pharmaceutical supply vehicle supporting global military healthcare programs.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a prominent pharmaceutical distribution and healthcare solutions provider. The company's federal contract portfolio demonstrates extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This particular delivery order for Zepbound, a diabetes medication, exemplifies the company's role in supplying prescription medications to support Defense Health Agency and other federal healthcare systems worldwide through flexible and comprehensive contracting vehicles.
Quick answers
Who was awarded contract SPE2DR26FL0WW?
SPE2DR26FL0WW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FL0WW worth?
The government has obligated $14,704 on SPE2DR26FL0WW.
Is contract SPE2DR26FL0WW an order under another contract?
Yes. SPE2DR26FL0WW is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL0WW competed?
The extent of competition for SPE2DR26FL0WW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award